Skip to main content
Merus Labs International Inc. logo

Merus Labs International Inc. — Investor Relations & Filings

Ticker · MSL ISIN · CA59047R1010 TSX Manufacturing
Filings indexed 147 across all filing types
Latest filing 2017-07-20 Regulatory Filings
Country CA Canada
Listing TSX MSL

About Merus Labs International Inc.

http://www.meruslabs.com

Merus Labs International Inc. was a specialty pharmaceutical company focused on the acquisition, licensing, ownership, marketing, and distribution of established branded pharmaceutical products. The company leveraged its expertise to manage a diversified portfolio primarily across Europe and North America. Its product offerings included pharmaceuticals used to treat acute and chronic coronary artery disease (such as nitrates), alongside other therapeutic areas like women's health. The core business strategy centered on acquiring mature assets to generate sustained revenue.

Recent filings

Filing Released Lang Actions
Notice.pdf
Regulatory Filings
2017-07-20 English
News release - English.pdf
Regulatory Filings
2017-07-17 English
News release - English.pdf
Regulatory Filings
2017-07-13 English
Report of voting results.pdf
Regulatory Filings
2017-07-10 English
News release - English.pdf
Regulatory Filings
2017-07-10 English
News release - English.pdf
Regulatory Filings
2017-07-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.